Koyfin Home > Directory > Health Care > Acceleron Pharma > EV / EBITDA (ntm)

Acceleron Pharma EV / EBITDA (ntm) Chart (XLRN)

Acceleron Pharma annual/quarterly EV / EBITDA (ntm) from 2020 to 2020. Enterprise multiple, also known as the EBITDA multiple, is a ratio used to determine the value of a company. It uses the consensus estimate EBITA over the next twelve months (NTM). The enterprise multiple looks at a firm in the way a potential acquirer might by considering the company's debt, which other multiples such as P/E do not include.
Other Valuation Metrics:
  • Acceleron Pharma Market Cap for the quarter ending March 03, 2018 was $1,776m a 33.91% increase of 602m year over year
  • Acceleron Pharma Price / Book for the quarter ending March 03, 2018 was 4.85 a -16.20% decrease of -0.78 year over year
  • Acceleron Pharma Enterprise Value for the quarter ending March 03, 2018 was $1,499m a 31.12% increase of 466m year over year
View Chart On Koyfin